Abstract
Salmonella Typhi infection in a patient in Pakistan initially responded to standard treatment but failed to respond to subsequent treatment. The first strain was susceptible to carbapenems and azithromycin; subsequent strains harbored the NDM-5 gene. Treatment with a combination of intravenous meropenem and colistin was successful. Carbapenem-resistant Salmonella Typhi emergence will hinder treatment.
Original language | English |
---|---|
Pages (from-to) | 2395-2397 |
Number of pages | 3 |
Journal | Emerging Infectious Diseases |
Volume | 29 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2023 |
Bibliographical note
Publisher Copyright:© 2023 Centers for Disease Control and Prevention (CDC). All rights reserved.